Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMP-9 Inhibition for Recalcitrant Wet Age-Related Macular Degeneration (AMD)
NCT04504123Phase 2Recruiting
- Sponsor
- University of Iowa
- Start
- Nov 2020
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in exudative macular degeneration, sponsored by University of Iowa. Started Nov 2020; status: recruiting.
02
Drugs
doxycycline
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on NCT04504123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04504123.